C9, t11-CLA
C9, t11-CLA is an active isomer of conjugated linoleic acid (CLA) . c9, t11-CLA has multiple physiological activities such as anti-cancer, anti-atherosclerosis, anti-obesity, anti-diabetes and anti-hypertension. The main regulatory mechanism of c9, t11-CLA is related to the regulation of cell signaling pathways and metabolic processes. c9, t11-CLA can be used in functional foods, drug development and health-related research[1].
Product Specifications
UNSPSC
12352211
Target
Endogenous Metabolite
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer; Metabolic Disease; Cardiovascular Disease
Smiles
CCCCCC/C=C/CC/C=C\CCCC(O)=O
Molecular Formula
C16H28O2
Molecular Weight
252.39
References & Citations
[1]Li Z, et al. A green and efficient two-step enzymatic esterification-hydrolysis method for enrichment of c9, t11-CLA isomer based on a three-liquid-phase system. RSC Adv. 2023 Sep 6;13 (38) :26690-26699.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1096493-01 0.02 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Autophagy-related protein 17 (atg17)
Ask
View Details MBS1096493-02 0.02 mg (Yeast)
Recombinant Schizosaccharomyces pombe Autophagy-related protein 17 (atg17)
Ask
View Details 
MBS1096493-03 0.1 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Autophagy-related protein 17 (atg17)
Ask
View Details 
MBS1096493-04 0.1 mg (Yeast)
Recombinant Schizosaccharomyces pombe Autophagy-related protein 17 (atg17)
Ask
View Details MBS1096493-05 0.02 mg (Baculovirus)
Recombinant Schizosaccharomyces pombe Autophagy-related protein 17 (atg17)
Ask
View Details MBS1096493-06 0.02 mg (Mammalian-Cell)
Recombinant Schizosaccharomyces pombe Autophagy-related protein 17 (atg17)
Ask
View Details